Notably, Rotolo and colleagues have demonstrated that in NSCLC, PD-1 expression is observed on tumor cells, particularly following cisplatin treatment, where it correlates with chemoresistance and stem-like features [254]. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.